{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/65736d39d32e730012c98919/68e90723f513ad2b8114eb3d?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Nobel Prizes Announced and Breakthroughs for Huntington’s and Rare Diseases","description":"<p>Metal-organic frameworks and peripheral immune tolerance were the big winners of the Nobel prizes in chemistry, and in physiology or medicine, respectively. In this episode of the podcast, we discuss the winners and the impacts of their discoveries. Then we move over to some business news where we discuss a novel gene therapy for Huntington’s disease from uniQure that made waves recently. Early clinical trial data for AMT-130 showed that it could meaningfully slow the progression of the disease by as much as 75%. Also in business news, a new partnership involving Arbor Biotechnologies and Chiesi Group aims to develop gene editing therapies to target rare liver diseases. </p><p><br></p><p>Join <em>GEN</em> editors Corinna Singleman, PhD, Alex Philippidis, and Uduak Thomas for a discussion of the latest biotech and biopharma news.&nbsp;</p><p>Listed below are links to the <em>GEN</em> stories referenced in this episode of <em>Touching Base</em>:</p><p><a href=\"https://www.genengnews.com/news/brunkow-ramsdell-sakaguchi-win-nobel-prize-in-physiology-or-medicine-for-peripheral-immune-tolerance/\" rel=\"noopener noreferrer\" target=\"_blank\">Brunkow, Ramsdell, Sakaguchi Win Nobel Prize in Physiology or Medicine for Peripheral Immune Tolerance</a></p><p>Uduak Thomas, <em>GEN</em>, October 6, 2025</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/translational-medicine/metal-organic-frameworks-win-the-2025-nobel-prize-in-chemistry/\" rel=\"noopener noreferrer\" target=\"_blank\">Metal-Organic Frameworks Win the 2025 Nobel Prize in Chemistry</a></p><p>Julianna LeMieux, PhD, <em>GEN</em>, October 8, 2025</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/genome-editing/gene-therapy-significantly-slows-huntington-disease-progression/\" rel=\"noopener noreferrer\" target=\"_blank\">Gene Therapy Significantly Slows Huntington Disease Progression</a></p><p><em>GEN,</em> September 24, 2025</p><p>&nbsp;</p><p><a href=\"https://www.genengnews.com/topics/translational-medicine/stockwatch-uniqure-shares-reach-five-year-high-on-game-changing-huntingtons-data/\" rel=\"noopener noreferrer\" target=\"_blank\">StockWatch: uniQure Shares Reach Five-Year High on “Game Changing” Huntington’s Data</a></p><p>Alex Philippidis<em>, GEN Edge,</em> September 28, 2025</p><p>&nbsp;</p><p><a href=\"https://www.genengnews.com/topics/genome-editing/chiesi-arbor-target-rare-liver-diseases-in-up-to-2-1b-gene-editing-collaboration/\" rel=\"noopener noreferrer\" target=\"_blank\">Chiesi, Arbor Target Rare Liver Diseases in Up-to-$2.1B Gene Editing Collaboration</a></p><p>Alex Philippidis,<em> GEN Edge,</em> October 8, 2025</p><p><br></p><p><a href=\"https://www.genengnews.com/category/multimedia/podcasts/touching-base/\" rel=\"noopener noreferrer\" target=\"_blank\">Touching Base Podcast</a></p><p>Hosted by Corinna Singleman, PhD</p>","author_name":"Genetic Engineering & Biotechnology News (GEN)"}